Affordable Access

Publisher Website

Percutaneous transluminal coronary angioplasty: The second decade

Authors
Publisher
Elsevier Inc.
Publication Date
Volume
62
Issue
18
Identifiers
DOI: 10.1016/0002-9149(88)90098-7
Disciplines
  • Design
  • Medicine

Abstract

Abstract Over the last decade, percutaneous transluminal coronary angioplasty has become a major therapeutic technique of myocardial revascularization. Advances in catheter design and operator experience have made angioplasty a viable alternative for many patients with both single- and multivessel disease who would otherwise require bypass surgery. Acute closure and restenosis remain the 2 principal limitations of angioplasty. Means of controlling these problems, including intracoronary stenting and antiplatelet and thrombolytic agents, are now being studied. Furthermore, controlled prospective randomized trials are underway to assess the value of angioplasty compared with coronary bypass surgery in the treatment of multivessel disease. These trials will help to establish the limits of coronary angioplasty and its relative advantages in terms of therapeutic results and costs.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Percutaneous transluminal coronary angioplasty: th...

on The American Journal of Cardio... Dec 06, 1988

[Secondary prevention in patients before and after...

on Schweizerische medizinische Wo... Apr 05, 1997

An unusual case with partial success of second per...

on Japanese circulation journal October 1985
More articles like this..